Discovering potential drug-targets for personalized treatment of autoimmune disorders - what we learn from epidermolysis bullosa acquisita.
about
Raising Awareness Among Healthcare Providers about Epidermolysis Bullosa and Advancing Toward a Cure.Reduced skin blistering in experimental epidermolysis bullosa acquisita after anti-TNF treatment.T cells mediate autoantibody-induced cutaneous inflammation and blistering in epidermolysis bullosa acquisita.Regulatory T Cells Suppress Inflammation and Blistering in Pemphigoid Diseases.Diagnosis of Autoimmune Blistering Diseases
P2860
Discovering potential drug-targets for personalized treatment of autoimmune disorders - what we learn from epidermolysis bullosa acquisita.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Discovering potential drug-tar ...... idermolysis bullosa acquisita.
@en
type
label
Discovering potential drug-tar ...... idermolysis bullosa acquisita.
@en
prefLabel
Discovering potential drug-tar ...... idermolysis bullosa acquisita.
@en
P2093
P2860
P1476
Discovering potential drug-tar ...... pidermolysis bullosa acquisita
@en
P2093
Hiroshi Koga
Katja Bieber
Mareike Witte
P2860
P304
P356
10.1517/14728222.2016.1148686
P407
P577
2016-02-19T00:00:00Z